| Nov 8 |
Tempus AI reports Q3 results
|
| Nov 7 |
Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56
|
| Nov 7 |
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test
|
| Nov 7 |
Exciting Growth Potential Ahead for Tempus AI (TEM)
|
| Nov 6 |
Tempus AI to buy genetic testing company for $600M
|
| Nov 6 |
Tempus AI Reports Growth and Strategic Acquisition
|
| Nov 5 |
Tempus AI Shares Fall After Reporting Q3 Loss, Deal to Acquire Ambry Genetics for $600 Million
|
| Nov 5 |
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
|
| Nov 5 |
Q3 2024 Tempus AI Inc Earnings Call
|
| Nov 5 |
Tempus AI Inc (TEM) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ...
|
